Literature DB >> 18221422

Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress.

Raanan Shamir1, Haifa Kassis, Marielle Kaplan, Tova Naveh, Naim Shehadeh.   

Abstract

INTRODUCTION: Atherosclerosis begins in childhood, and diabetes is a risk factor for coronary heart disease. Dyslipidemia is prevalent in children with type 1 diabetes mellitus (T1DM), with an association between elevated hemoglobin A1c (HbA1c), serum lipid levels, and oxidative stress. Our aim was to examine the effect of metabolic control on serum lipid levels and oxidative stress in adolescents with T1DM.
METHODS: Twenty-six adolescents (13 boys and 13 girls), aged 15.65 +/- 1.5 yr, with disease duration of 5.9 +/- 2.8 yr and average HbA1c 10.8 +/- 1.9% were assigned to intensive insulin therapy for 3 months. Comparisons for HbA1c, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein cholesterol, total triglycerides (TG), total cholesterol (TC), apolipoprotein AI, apolipoprotein AII, apolipoprotein B (ApoB), and thiobarbituric acid reactive substances (TBARS) were done between patients whose HbA1c improved by 0.5% or more (GR1) and the rest of the cohort (patients whose HbA1c improved by <0.5%, did not change, or increased) (GR2).
RESULTS: ApoB (p = 0.047) and TBARS (p = 0.01) were significantly lower at the end of the study in GR1. In GR2, TC (p = 0.01) and LDL (p = 0.03) were significantly higher at study end. Overall, significant beneficial changes in TC (p = 0.006), TG (p = 0.04), LDL (p = 0.02), ApoB (p = 0.015), and oxidative stress (p = 0.001) were found in GR1 compared with GR2.
CONCLUSIONS: We provide direct evidence for the beneficial effect of tight metabolic control on serum lipids and oxidative stress in adolescents with T1DM, indicating that tight metabolic control may reduce cardiovascular risk in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221422     DOI: 10.1111/j.1399-5448.2007.00313.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  9 in total

Review 1.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors:  Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

2.  Overweight adolescents with type 2 diabetes have significantly higher lipoprotein abnormalities than those with type 1 diabetes.

Authors:  Lynae J Hanks; James Heath Pelham; Shalini Vaid; Krista Casazza; Ambika P Ashraf
Journal:  Diabetes Res Clin Pract       Date:  2016-03-07       Impact factor: 5.602

3.  Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus.

Authors:  Sheela N Magge
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-09-25

4.  Serum lipid profiles and glycemic control in adolescents and young adults with type 1 diabetes mellitus.

Authors:  Shin-Hee Kim; In-Ah Jung; Yeon Jin Jeon; Won Kyoung Cho; Kyoung Soon Cho; So Hyun Park; Min Ho Jung; Byoung Kyu Suh
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-12-31

Review 5.  Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

Authors:  Sarah D de Ferranti; Ian H de Boer; Vivian Fonseca; Caroline S Fox; Sherita Hill Golden; Carl J Lavie; Sheela N Magge; Nikolaus Marx; Darren K McGuire; Trevor J Orchard; Bernard Zinman; Robert H Eckel
Journal:  Diabetes Care       Date:  2014-08-11       Impact factor: 19.112

6.  Intensive insulin therapy increases glutathione synthesis rate in surgical ICU patients with stress hyperglycemia.

Authors:  Gianni Biolo; Benedetta Massolino; Filippo Giorgio Di Girolamo; Nicola Fiotti; Filippo Mearelli; Sara Mazzucco; Carlos Bertuzzi; Renzo Lazzarini; Alfonso Colombatti; Marcello De Cicco
Journal:  PLoS One       Date:  2018-01-04       Impact factor: 3.240

7.  Lipid Profile in Relation to Glycemic Control in Type 1 Diabetes Children and Adolescents in Bangladesh.

Authors:  Bedowra Zabeen; Ana Margarida Balsa; Nasreen Islam; Mukta Parveen; Jebun Nahar; Kishwar Azad
Journal:  Indian J Endocrinol Metab       Date:  2018 Jan-Feb

8.  Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology--New Possibility to Decrease Cardiovascular Risk?

Authors:  Milena Jamiołkowska; Izabela Jamiołkowska; Włodzimierz Łuczyński; Joanna Tołwińska; Artur Bossowski; Barbara Głowińska Olszewska
Journal:  J Diabetes Res       Date:  2015-11-16       Impact factor: 4.011

9.  Insulin therapy with personal insulin pumps and early angiopathy in children with type 1 diabetes mellitus.

Authors:  Joanna Tołwińska; Barbara Głowińska-Olszewska; Artur Bossowski
Journal:  Mediators Inflamm       Date:  2013-11-14       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.